Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections
Anne M. Neilan(Harvard University), Andrea Ciaranello(Harvard University), Rochelle P. Walensky(Harvard University), Kimberly A. Powers(University of North Carolina at Chapel Hill), Catherine M. Crespi(University of California, Los Angeles), Allison L. Agwu(Johns Hopkins University), Aditya H. Gaur(St. Jude Children's Research Hospital), Caitlin M. Dugdale(Harvard University), Kunjal Patel(Cancer Research And Biostatistics), Emily P. Hyle(Harvard University), H. Jonathon Rendina(City University of New York), Ingrid V. Bassett(Apple (Israel)), Kenneth A. Freedberg(Harvard University), Michael G. Hudgens(University of North Carolina at Chapel Hill), Audrey C. Bangs(Massachusetts General Hospital), Milton C. Weinstein, Keith J. Horvath(San Diego State University)
Cited by 10
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
|JAMA Network Open|2020|532
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
|New England Journal of Medicine|2001|519